STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Janus Henderson Files Schedule 13G/A for IDEAYA, Discloses 6.9% Stake

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Janus Henderson Group plc filed Amendment No. 4 to a Schedule 13G reporting its beneficial ownership of IDEAYA BIOSCIENCES, INC. common stock (CUSIP 45166A102). The filing lists an aggregate beneficial ownership of 6,206,238 shares, representing 6.9% of the class, tied to an event date of 06/30/2025. The report shows no sole voting or dispositive power and shared voting and dispositive power of 6,206,238 shares, while Item 4 separately notes that JHIUS may be deemed beneficial owner of 6,080,532 shares. The reporting person is identified as an investment adviser/holding company (IA, HC). The statement is signed by Kristin Mariani on 08/14/2025 and includes a Power of Attorney exhibit dated 12/09/2022.

Positive

  • Aggregate ownership exceeds 5% disclosure threshold: 6,206,238 shares (6.9%) reported, providing transparency to the market
  • Filing discloses subsidiary adviser roles and Power of Attorney: JHIUS, JHIUKL and JHIAIFML identified as indirect subsidiaries and registered investment advisers, enhancing clarity on which entities manage the position

Negative

  • None.

Insights

TL;DR: Routine >5% disclosure; reports a meaningful passive stake in IDEAYA without sole control.

The filing documents an aggregate position of 6,206,238 shares (6.9%), triggering Schedule 13G reporting thresholds. The absence of sole voting or dispositive power and the stated shared powers indicate holdings are managed collectively rather than reflecting unilateral control. The Item 4 note that JHIUS may be deemed owner of 6,080,532 shares provides additional granularity about which subsidiary accounts for a sub-portion of the reported stake. This is a material, but routine, ownership disclosure for investors monitoring large holders.

TL;DR: Disclosure shows transparency on voting/dispositive arrangement and adviser/subsidiary roles, not an activist control claim.

The Schedule identifies Janus Henderson Group plc as the reporting entity and classifies it as IA, HC. Item 7 states that JHIUS, JHIUKL and JHIAIFML are indirect subsidiaries and registered investment advisers providing advice to Managed Portfolios. The filing also includes a Power of Attorney executed in 2022 and a certification that the securities are held in the ordinary course of business and not for purposes of changing control. These elements support a characterization of a portfolio/managed holding rather than an intention to influence issuer control.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



JANUS HENDERSON GROUP PLC
Signature:Kristin Mariani
Name/Title:Head of North America Compliance, CCO
Date:08/14/2025
Exhibit Information

POWER OF ATTORNEY The undersigned, Janus Henderson Group plc ("the Company"), does hereby make, constitute and appoint each of Kristin Mariani and Caroline Barotti acting severally, as its true and lawful attorneys in-fact, for the purpose of, from time to time, executing in its name and on its behalf, whether the Company individually or as representative of others, any and all documents, certificates, instruments, statements, other filings and amendments to the foregoing (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including, without limitation, Forms 13D, 13F, 13G and 13H and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental, regulatory authority or other person, and giving and granting to each such attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 9th day of December, 2022. Janus Henderson Group plc By: /s/ Michelle Rosenberg Name: Michelle Rosenberg Title: General Counsel and Company Secretary

Ideaya Biosciences

NASDAQ:IDYA

IDYA Rankings

IDYA Latest News

IDYA Latest SEC Filings

IDYA Stock Data

3.01B
86.87M
0.91%
115.11%
11.51%
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO